Antigua and Barbuda | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2013 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Antigua and Barbuda totalled $ 419 thousand in 2023. Sales of commodity group 30 from Antigua and Barbuda went up by 241% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 296 thousand (cumulative exports of commodity group 30 from Antigua and Barbuda amounted $122 thousand in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 1.37% of total exports from Antigua and Barbuda (cumulative merchandise exports from Antigua and Barbuda totalled $ 30 million in 2023). The share of commodity group 30 in total exports from Antigua and Barbuda increased by 0.812 p.p. compared to 2022 (it was 0.561% in 2022 and cumulative exports from Antigua and Barbuda were equal to $ 21 million).
Where does Antigua and Barbuda export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Antigua and Barbuda in 2023:
- Montserrat with a share of 41% (172 thousand US$)
- Trinidad and Tobago with a share of 29% (122 thousand US$)
- Saint Kitts and Nevis with a share of 9.71% (40 thousand US$)
- USA with a share of 5.02% (21 thousand US$)
- Saint Maarten with a share of 4.61% (19.3 thousand US$)
- British Virgin Islands with a share of 3.9% (16.3 thousand US$)
- Saint Vincent and the Grenadines with a share of 2.52% (10.6 thousand US$)
- Panama with a share of 2.07% (8.69 thousand US$)
- Dominica with a share of 1.83% (7.71 thousand US$)
- United Kingdom - 124 US$
Exports structure of 30 - Pharmaceutical products - from Antigua and Barbuda in 2023 represented by the following main commodity groups:
- 65% (276 thousand US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 30% (128 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.54% (10.6 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.851% (3.57 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.037% (159 US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
The value of imports of commodity group 30 "Pharmaceutical products" to Antigua and Barbuda totalled $ 11.5 million in 2023. Sales of commodity group 30 to Antigua and Barbuda went up by 7.94% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 852 thousand (the value of imports of commodity group 30 to Antigua and Barbuda was equal to $10.7 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 1.72% of total import flow to Antigua and Barbuda (in 2023, total imports to Antigua and Barbuda amounted to $ 669 million). The share of commodity group 30 in total imports to Antigua and Barbuda increased by 0.007 p.p. compared to 2022 (it was 1.72% in 2022 and cumulative imports to Antigua and Barbuda were equal to $ 622 million).
Imports of commodity group 30 reached 99% of total imports of group 30 "Pharmaceutical products" to Antigua and Barbuda in 2023 (imports of commodity group 30 to Antigua and Barbuda totalled $11.5 million in 2023). The share of purchases of commodity group 30 in imports of commodity group 30 to Antigua and Barbuda went down by 0 p.p. compared to 2022 (it was 100% in 2022, and imports of commodity group 30 to Antigua and Barbuda accounted for $10.7 million).
Where does Antigua and Barbuda import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Antigua and Barbuda in 2023:
- USA with a share of 29% (3.36 million US$)
- United Kingdom with a share of 16.4% (1.9 million US$)
- Germany with a share of 11.2% (1.29 million US$)
- Spain with a share of 7.84% (909 thousand US$)
- Barbados with a share of 7.1% (822 thousand US$)
- France with a share of 4.19% (485 thousand US$)
- India with a share of 3.88% (449 thousand US$)
- Panama with a share of 2.95% (341 thousand US$)
- Switzerland with a share of 1.97% (228 thousand US$)
- Canada with a share of 1.83% (212 thousand US$)
Imports structure of 30 - Pharmaceutical products - to Antigua and Barbuda in 2023 represented by the following main commodity groups:
- 94% (10.9 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 1.93% (223 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.65% (191 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.43% (166 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.339% (39 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0.052% (6.05 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
